# Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding

**Authors:** Jian-Ying Tang, Lu Yang, Jing Wang, Ying Yang, Jun-Chen Li, Jiao Mu

PMC · DOI: 10.1093/ckj/sfae175 · 2024-06-13

## Full-text entities

- **Diseases:** conjunctival bleeding (MESH:D003229)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC11252668